Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants
暂无分享,去创建一个
Sarah Rowland-Jones | Susan Daenke | Andrew J. McMichael | P. Klenerman | S. Rowland-Jones | R. Phillips | A. McMichael | A. Edwards | P. Giangrande | D. Lalloo | S. Daenke | Paul Klenerman | Rodney E. Phillips | W. Rosenberg | J. Edwards | Anne Edwards | Steve McAdam | Jon Edwards | David Lalloo | Britta Köppe | William Rosenberg | Diana Boyd | Paul Giangrande | D. Boyd | B. Köppe | S. McAdam | Britta Köppe | R. Phillips
[1] D. Nixon,et al. Cytotoxic T-cell recognition of HIV proteins and peptides. , 1991, AIDS.
[2] P. Allen,et al. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. , 1991, Science.
[3] H. Grey,et al. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor , 1992, Cell.
[4] S. Rowland-Jones,et al. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides , 1993, European journal of immunology.
[5] D. Nixon,et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.
[6] S. Rowland-Jones,et al. An antigen processing polymorphism revealed by HLA‐B8‐restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism , 1993, European Journal of Immunology.
[7] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[8] B. Walker,et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. , 1988, Science.
[9] Kristin A. Hogquist,et al. T cell receptor antagonist peptides induce positive selection , 1994, Cell.
[10] M. Bevan,et al. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells , 1993, The Journal of experimental medicine.
[11] H. Temin,et al. Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication , 1988, Journal of virology.
[12] R. Germain,et al. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling , 1993, The Journal of experimental medicine.
[13] J. Sidney,et al. T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues. , 1993, Journal of immunology.
[14] B. Moss,et al. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes , 1984, Journal of virology.
[15] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[16] P. Allen,et al. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. , 1993, Immunology today.
[17] P. Simmonds,et al. Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. , 1991, AIDS.